Business
AstraZeneca likely to run new COVID-19 vaccine trial, CEO says, as questions emerge – Sydney Morning Herald
The company is likely to conduct an additional global vaccine trial after current studies raised questions over its level of protection.
Soriot said he didn’t expect the additional trial to hold up regulatory approvals in the UK and European Union.
Clearance from the US Food and Drug Administration may take longer because the regulator is unlikely to approve the vaccine on the basis of studies conducted elsewhere, especially given the questions over the results, he said. Authorisation in some countries is still expected before the end of the year, he said.
AstraZeneca and its CEO are facing scrutiny as the drugmaker responds to growing…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News23 hours agoNoosa MP calls for solutions to curb reckless electric bike usage
-
Noosa News23 hours agoNicole Kidman Is Back in Wellness Guru Mode: ‘Nine Perfect Strangers’ Season Two Will Hit Your Streaming Queue in May
-
Noosa News20 hours agoCloud Control celebrate 15 years of debut album Bliss Release with reunion tour